HHS Selects 15 New Drugs for Medicare Part D Price Negotiations
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices expected to take effect in 2027.
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people w
Medicare targets 15 more drugs for price negotiations — including Ozempic
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
Latest Medicare price drug negotiations includes Ozempic, Wegovy
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.
Trump rolls back effort to lower Medicare, Medicaid drug costs
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
Trump Urged to Keep Biden Law That Lowered Medicare Drug Prices
A group of lawmakers are urging President Donald Trump to reject pharmaceutical companies’ efforts to pause the Biden administration’s drug-price cuts.
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
Trump rolls back Biden directive to study methods of lowering prescription costs
Among the dozens of Biden-era executive orders he rescinded on day one, President Trump nixed one that aimed to explore new health care payment models that would lower prescription costs for Medicare and Medicaid beneficiaries.
Yes, Trump rescinded Biden's order to lower prescription drug costs for people on Medicare and Medicaid
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.
HHS Secretary Becerra urges Trump administration to 'continue to grow' the ACA
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...
Departed Biden Medicare Chief Lauds Landmark Drug Negotiations
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
STAT8d
Former Trump White House, HHS aide Abe Sutton likely to lead Medicare, Medicaid innovation center
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
MM&M4d
Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Fierce Healthcare4d
Former HHS official and Warp Speed leader Paul Mango dies
Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...
McKnight's Long-Term Care News6d
HHS targets private equity, pushes for more SNF ownership transparency in new report
A new Health and Human Services report is calling for greater transparency in long-term care ownership, calling out private ...
Healthcare Dive43m
Americans mixed on potential Trump healthcare priorities: KFF poll
About half of respondents said the nation should spend more on Medicaid and Medicare — a potential challenge for the Trump administration looking to cut costs.
Fierce Healthcare23h
What Trump's first day orders mean for healthcare: Ditched drug models, pauses on rules and hiring
President Donald Trump made good on his campaign promises to kick off his second term in office with a tidal wave of ...